Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Mounjaro vs Semaglutide: Head-to-Head Comparison (2026)
comparisonMounjaro is tirzepatide; semaglutide is Ozempic and Wegovy. Compare mechanism, SURMOUNT-5 trial data, side effects, FDA indications, and dosing side by side.
Tirzepatide Calculator & Guide: Mounjaro & Zepbound Dosing (2026)
hubFree tirzepatide dosing calculator plus complete guide. Visualize Mounjaro/Zepbound drug levels, plan titration schedules, understand half-life pharmacokinetics, and manage side effects.
Wegovy vs Zepbound: Head-to-Head Comparison (SURMOUNT-5 Data)
comparisonSURMOUNT-5 compared tirzepatide and semaglutide head-to-head for the first time. See the weight loss numbers, mechanism differences, dosing schedules, and which drug may fit your situation.
Zepbound Side Effects: Complete Guide for Weight Loss Patients
guideZepbound side effects guide: nausea 25-29%, diarrhea 19-23%, symptom timeline, serious warnings, and practical management tips for weight loss patients.
Semaglutide Side Effects: Ozempic, Wegovy & Rybelsus Complete Guide (2026)
guideSemaglutide side effects guide: nausea, diarrhea, and GI symptoms from STEP and SUSTAIN trials, plus practical management tips.
Retatrutide Guide: Dosing, Results, Calculator & Side Effects (2026)
hubThe ultimate retatrutide resource hub. Learn about this investigational triple-agonist, its remarkable Phase 2 results, dosing schedules, microdosing protocols, and use our free calculator to plan your journey.
GLP-1 Side Effects: Retatrutide, Tirzepatide & Semaglutide Compared
guideRetatrutide side effects guide: nausea, diarrhea, and other GI symptoms from Phase 2 clinical trial data, plus management strategies.
Retatrutide Nausea Management: How to Reduce GI Side Effects
articleA practical retatrutide nausea management guide covering the mechanism, Phase 2 trial data, the dose step-back protocol, and dietary strategies.
Tirzepatide Side Effects: What to Expect & How to Manage (2026 Guide)
guideTirzepatide side effects guide: nausea, diarrhea, and other GI symptoms from clinical trial data, plus practical management tips.
Semaglutide Constipation: Why It Happens and How to Manage It
articleA semaglutide constipation guide built on the Wegovy label, covering the mechanism, label-verified incidence, relief strategies, and when constipation becomes an emergency.
Semaglutide Nausea Management: What the Wegovy Label Says
articleA semaglutide nausea management guide built on the Wegovy label's own numbers and escalation language, not generic tips.
Semaglutide Guide: Ozempic & Wegovy Complete Resource
hubEverything you need to know about semaglutide (Ozempic/Wegovy): GLP-1 mechanism, FDA-approved dosing protocols, half-life pharmacokinetics, side effects, and our free calculator to track your journey.
Zepbound vs Wegovy Comparison Chart: Tirzepatide vs Semaglutide
comparisonOne chart, all the numbers that matter. Zepbound (tirzepatide) and Wegovy (semaglutide) compared row by row using SURMOUNT-5 head-to-head data, dosing ladders, cost, and FDA approvals.
Zepbound Weight Loss Results: SURMOUNT-1 Dose-Stratified Data
articleThe dose-stratified Zepbound weight loss results from SURMOUNT-1 (5mg, 10mg, 15mg arms) with per-dose responder rates, plus SURMOUNT-2 (T2D), SURMOUNT-4 (maintenance), and SURMOUNT-5 (vs Wegovy) context. Brand-specific Zepbound evidence, FDA-label population.
Zepbound Dosing Schedule: A Week-by-Week Patient Journey Guide
articleThe patient-journey view of the Zepbound dosing schedule. Maps weeks 1 through 21+ across four phases, with maintenance decision criteria, missed-dose rules, and day-change guidance grounded in the FDA prescribing information.